Hypericin attenuates nonalcoholic fatty liver disease and abnormal lipid metabolism via the PKA-mediated AMPK signaling pathway in vitro and in vivo
Liang Chen, Yan Li, Yan Li, Miao Bai, Yanxin Huang, Hang Yang, Lei Liu, Shuyue Wang, Chunlei Yu, Zhenbo Song, Yongli Bao, Jingwen Yi, Luguo Sun, Yuxin Li, Yuxin Li
Topics & Concepts
Nonalcoholic fatty liver diseaseAMPKLipogenesisLipid metabolismMedicineCirrhosisPharmacologyFatty liverHepatocellular carcinomaIn vivoCancer researchInternal medicineDiseaseBiologyBiochemistryProtein kinase AEnzymeBiotechnologyDiet, Metabolism, and DiseaseLiver Disease Diagnosis and TreatmentMetabolism, Diabetes, and Cancer